Most Indian businesses are locally competitive. You take them outside India, and they struggle. Very few businesses (IT, Pharma/API, Chemicals/CDMO) are fit to compete and beat global competition. These rare gems tend to survive over long time periods and thrive over all cycles.
More from Sajal Kapoor
You offer me 80% cost arbitrage (discount relative to Japan/EU/US) along with low confidence / assurance on Critical Success Factors and I won't give you a single NCE/NBE to discover, develop or manufacture. Capex/opex arbitrage is too low in the disruptive-science-pecking-order! https://t.co/O2l8dK4BUv
@unseenvalue Given high capex/opex cost structures of US/Japan/EU, how will they be able to compete with Indian API companies? https://t.co/OYhC2PUZpL
— Hiren (@hiren_investing) August 11, 2021
More from Praj
Somewhere in the second half, we ask @joshipuras about how would he mitigate the impact of rising costs, which impacted op metrics his Q... That, and more on order booking and execution, and the sharp pick-up in ethanol ordering #TaklingPoint @BloombergQuint with @PrajIndustries
Talking Point | Praj Industries' revenue & net profit contract in Q1 but earnings are better than expectations.
— BloombergQuint (@BloombergQuint) August 13, 2021
MD & CEO Shishir Joshipura talks about the quarter gone by and growth acceleration led by the government's ethanol push. @_nirajshah #BQLive https://t.co/DzSARyZ2Ti